AI Article Synopsis
- A 10% intravenous immunoglobulin (IVIG) treatment for Kawasaki disease was more effective than a 5% IVIG, reducing fever duration among responders from 13 hours to 10 hours.
- It also shortened the time to additional therapy for nonresponders from 49 hours to 47 hours.
- The study found no severe adverse events related to the treatment.
Article Abstract
Compared with a 5% intravenous immunoglobulin, a 10% intravenous immunoglobulin as the first-line treatment of Kawasaki disease significantly reduced the fever duration (10 vs 13 hours, P = .022) among the responders, and the interval to adjunctive therapy for nonresponders (47 vs 49 hours, P = .035). There were no severe adverse events.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jpeds.2019.06.018 | DOI Listing |
Publication Analysis
Top Keywords
intravenous immunoglobulin
12
kawasaki disease
8
clinical utility
4
utility highly
4
highly purified
4
purified 10%
4
10% liquid
4
liquid intravenous
4
immunoglobulin kawasaki
4
disease compared
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!